Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions

EY Lin, PC Adamson, JD Klausner - Drugs, 2021 - Springer
Neisseria gonorrhoeae is the second most common bacterial sexually transmitted infection
in the world after Chlamydia trachomatis. The pathogen has developed resistance to every …

Multidisciplinary approaches identify compounds that bind to human ACE2 or SARS-CoV-2 spike protein as candidates to block SARS-CoV-2–ACE2 receptor …

CJ Day, B Bailly, P Guillon, L Dirr, FEC Jen… - MBio, 2021 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged virus
that causes coronavirus infectious disease 2019 (COVID-19). SARS-CoV-2 spike protein …

Sexually Transmitted Neisseria gonorrhoeae Infections—Update on Drug Treatment and Vaccine Development

A Jefferson, A Smith, PS Fasinu, DK Thompson - Medicines, 2021 - mdpi.com
Background: Sexually transmitted gonorrhea, caused by the Gram-negative diplococcus
Neisseria gonorrhoeae, continues to be a serious global health challenge despite efforts to …

All major cholesterol-dependent cytolysins use glycans as cellular receptors

LK Shewell, CJ Day, FEC Jen, T Haselhorst… - Science …, 2020 - science.org
Cholesterol-dependent cytolysins (CDCs) form pores in cholesterol-rich membranes, but
cholesterol alone is insufficient to explain their cell and host tropism. Here, we show that all …

Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus

W Daher, LD Leclercq, MD Johansen, C Hamela… - Cell chemical …, 2022 - cell.com
Mycobacterium abscessus is an emerging and difficult-to-manage mycobacterial species
that exhibits smooth (S) or rough (R) morphotypes. Disruption of glycopeptidolipid (GPL) …

[HTML][HTML] The essential malaria protein PfCyRPA targets glycans to invade erythrocytes

CJ Day, P Favuzza, S Bielfeld, T Haselhorst, L Seefeldt… - Cell Reports, 2024 - cell.com
Plasmodium falciparum is a human-adapted apicomplexan parasite that causes the most
dangerous form of malaria. P. falciparum cysteine-rich protective antigen (PfCyRPA) is an …

Repurposing the ionophore, PBT2, for treatment of multidrug-resistant Neisseria gonorrhoeae infections

FEC Jen, JL Edwards, IM El-Deeb… - Antimicrobial agents …, 2022 - Am Soc Microbiol
ABSTRACT Multidrug-resistant (MDR) N. gonorrhoeae is a current public health threat. New
therapies are urgently needed. PBT2 is an ionophore that disrupts metal homeostasis. PBT2 …

Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model

F Yang, S Gao, J Yan, X Lin… - Journal of Antimicrobial …, 2022 - academic.oup.com
Objectives Ceftriaxone therapy for gonorrhoea has become under increasing pressure due
to waning susceptibility levels and emergence of high-level resistant strains such as the …

Anti-Virulence Therapeutic Approaches for Neisseria gonorrhoeae

KYL Lim, CA Mullally, EC Haese, EA Kibble… - Antibiotics, 2021 - mdpi.com
While antimicrobial resistance (AMR) is seen in both Neisseria gonorrhoeae and Neisseria
meningitidis, the former has become resistant to commonly available over-the-counter …

Potent In Vitro and Ex Vivo Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin A

JL Edwards, JT Balthazar, DLA Esposito, JC Ayala… - Msphere, 2022 - Am Soc Microbiol
Gonorrhea remains a major global public health problem because of the high incidence of
infection (estimated 82 million cases in 2020) and the emergence and spread of Neisseria …